Clinical Trial Update: Dose Escalation Study Combining Oral Capecitabine (Xeloda) and Radiotherapy for Patients With Unresectable Liver or Cholangiocarcinoma [Phase 1]

View source ↗

Summary

Phase 1 dose-escalation trial evaluating oral capecitabine (Xeloda) with radiotherapy in patients with unresectable liver cancer or cholangiocarcinoma; the stud…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cholangiocarcinoma
• Hepatocellular Carcinoma

Drugs mentioned

• Capecitabine (Xeloda) (Capecitabine)

Snippet

Sponsor: James A. Haley Veterans Administration Hospital | Conditions: Cancer of Liver | Phase 1 | Status: TERMINATED